Serine hydroxymethyltransferase 1 promoter hypermethylation increases the risk of essential hypertension.
Guodong XuChangyi WangXiuru YingFanqian KongHuihui JiJinshun ZhaoXiaohong ZhangShiwei DuanLiyuan HanLi LiPublished in: Journal of clinical laboratory analysis (2018)
Our findings indicate that SHMT1 promoter hypermethylation increases the risk of EH and may be a promising biomarker for EH.